Terms: = Gastric cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Treatment
393 results:
1. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
[TBL] [Abstract] [Full Text] [Related]
2. Single cell and bulk RNA sequencing identifies tumor microenvironment subtypes and chemoresistance-related IGF1
Jia X; Li Z; Zhou R; Feng W; Yi L; Zhang H; Chen B; Li Q; Huang S; Zhu X
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167123. PubMed ID: 38484940
[TBL] [Abstract] [Full Text] [Related]
3. Identification of neutrophil extracellular trap-driven gastric cancer heterogeneity and C5AR1 as a therapeutic target.
Zhao J; Li X; Li L; Chen B; Xu W; He Y; Chen X
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):538-550. PubMed ID: 38425243
[TBL] [Abstract] [Full Text] [Related]
4. ROS-mediated up-regulation of SAE1 by Helicobacter pylori promotes human gastric tumor genesis and progression.
Shi L; Shangguan J; Lu Y; Rong J; Yang Q; Yang Y; Xie C; Shu X
J Transl Med; 2024 Feb; 22(1):148. PubMed ID: 38351014
[TBL] [Abstract] [Full Text] [Related]
5. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract] [Full Text] [Related]
6. Circular RNA circWNK1 inhibits the progression of gastric cancer via regulating the miR-21-3p/SMAD7 axis.
Dai T; Qiu S; Gao X; Zhao C; Ge Z; Yang Y; Tang C; Feng S
Cancer Sci; 2024 Mar; 115(3):974-988. PubMed ID: 38287200
[TBL] [Abstract] [Full Text] [Related]
7. Profiling Kinase Activities for Precision Oncology in Diffuse gastric cancer.
Singh S; Parthasarathi KTS; Bhat MY; Gopal C; Sharma J; Pandey A
OMICS; 2024 Feb; 28(2):76-89. PubMed ID: 38271566
[TBL] [Abstract] [Full Text] [Related]
8. Ubiquitin-specific Protease 35 Promotes gastric cancer Metastasis by Increasing the Stability of Snail1.
Ma C; Tian Z; Wang D; Gao W; Qian L; Zang Y; Xu X; Jia J; Liu Z
Int J Biol Sci; 2024; 20(3):953-967. PubMed ID: 38250150
[TBL] [Abstract] [Full Text] [Related]
9. Hyperthermic intraperitoneal chemotherapy for gastric cancer: a narrative review.
Chen C; Justo M; Gangi A
Chin Clin Oncol; 2023 Dec; 12(6):68. PubMed ID: 38195075
[TBL] [Abstract] [Full Text] [Related]
10. CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma.
Zeng S; Chen XI; Yi Q; Thakur A; Yang H; Yan Y; Liu S
Oncol Res; 2023; 32(2):261-272. PubMed ID: 38186580
[TBL] [Abstract] [Full Text] [Related]
11. Long-term MNNG exposure promotes gastric carcinogenesis by activating METTL3/m6A/miR1184 axis-mediated epithelial-mesenchymal transition.
Liu T; Feng YL; Wang RY; Yang S; Ge YL; Zhang TY; Li J; Li CY; Ruan Y; Luo B; Liang GY
Sci Total Environ; 2024 Feb; 913():169752. PubMed ID: 38163601
[TBL] [Abstract] [Full Text] [Related]
12. Paeoniflorin Induces ER Stress-Mediated Apoptotic Cell Death by Generating Nox4-Derived ROS under Radiation in gastric cancer.
Kim TW
Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140352
[TBL] [Abstract] [Full Text] [Related]
13. Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (emt).
Tangsiri M; Hheidari A; Liaghat M; Razlansari M; Ebrahimi N; Akbari A; Varnosfaderani SMN; Maleki-Sheikhabadi F; Norouzi A; Bakhtiyari M; Zalpoor H; Nabi-Afjadi M; Rahdar A
Biomed Pharmacother; 2024 Jan; 170():115973. PubMed ID: 38064969
[TBL] [Abstract] [Full Text] [Related]
14. Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the treatment of gastric cancer.
Gu H; Zhang T; Guan T; Wu M; Li S; Li Y; Guo M; Zhang L; Peng Y; Mi D; Liu M; Yi Z; Chen Y
J Med Chem; 2023 Dec; 66(24):16917-16938. PubMed ID: 38054798
[TBL] [Abstract] [Full Text] [Related]
15. Role of non-coding RNAs as new therapeutic targets in regulating the emt and apoptosis in metastatic gastric and colorectal cancers.
Ebrahimi N; Hakimzadeh A; Bozorgmand F; Speed S; Manavi MS; Khorram R; Farahani K; Rezaei-Tazangi F; Mansouri A; Hamblin MR; Aref AR
Cell Cycle; 2023 Oct; 22(20):2302-2323. PubMed ID: 38009668
[TBL] [Abstract] [Full Text] [Related]
16. Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery.
Hashemi M; Aparviz R; Beickzade M; Paskeh MDA; Kheirabad SK; Koohpar ZK; Moravej A; Dehghani H; Saebfar H; Zandieh MA; Salimimoghadam S; Rashidi M; Taheriazam A; Entezari M; Samarghandian S
Biomed Pharmacother; 2023 Dec; 169():115927. PubMed ID: 38006616
[TBL] [Abstract] [Full Text] [Related]
17. The Role of LncRNA NEAT1 in gastric cancer: Tumor Development and Potential Therapeutic Target.
Zhang Y; Wen Y
Curr Pharm Des; 2023; 29(28):2213-2222. PubMed ID: 37779403
[TBL] [Abstract] [Full Text] [Related]
18. Wnt/β-catenin pathway is a key signaling pathway to trastuzumab resistance in gastric cancer cells.
Kim Y; Bae YJ; Kim JH; Kim H; Shin SJ; Jung DH; Park H
BMC Cancer; 2023 Sep; 23(1):922. PubMed ID: 37773114
[TBL] [Abstract] [Full Text] [Related]
19. Targeting SALL4 by Entinostat Inhibits the Malignant Phenotype of gastric cancer Cells by Reducing emt Signaling.
DU L; Xie F; Han H; Zhang L
Anticancer Res; 2023 Oct; 43(10):4389-4401. PubMed ID: 37772555
[TBL] [Abstract] [Full Text] [Related]
20. EGCG-LYS Fibrils-Mediated CircMAP2K2 Silencing Decreases the Proliferation and Metastasis Ability of gastric cancer Cells in Vitro and in Vivo.
Dong J; Zheng Z; Zhou M; Wang Y; Chen J; Cen J; Cao T; Yang T; Xu Y; Shu G; Lu X; Liang Y
Adv Sci (Weinh); 2023 Nov; 10(32):e2304075. PubMed ID: 37752765
[TBL] [Abstract] [Full Text] [Related]
[Next]
